Associations of network-derived metabolite clusters with prevalent type 2 diabetes among adults of Puerto Rican descent

Introduction We investigated whether network analysis revealed clusters of coregulated metabolites associated with prevalent type 2 diabetes (T2D) among Puerto Rican adults. Research design and methods We used liquid chromatography-mass spectrometry to measure fasting plasma metabolites (>600) among participants aged 40–75 years in the Boston Puerto Rican Health Study (BPRHS; discovery) and San Juan Overweight Adult Longitudinal Study (SOALS; replication), with (n=357; n=77) and without (n=322; n=934) T2D, respectively. Among BPRHS participants, we used unsupervised partial correlation network-based methods to identify and calculate metabolite cluster scores. Logistic regression was used to assess cross-sectional associations between metabolite clusters and prevalent T2D at the baseline blood draw in the BPRHS, and significant associations were replicated in SOALS. Inverse-variance weighted random-effect meta-analysis was used to combine cohort-specific estimates. Results Six metabolite clusters were significantly associated with prevalent T2D in the BPRHS and replicated in SOALS (false discovery rate (FDR) <0.05). In a meta-analysis of the two cohorts, the OR and 95% CI (per 1 SD increase in cluster score) for prevalent T2D were as follows for clusters characterized primarily by glucose transport (0.21 (0.16 to 0.30); FDR <0.0001), sphingolipids (0.40 (0.29 to 0.53); FDR <0.0001), acyl cholines (0.35 (0.22 to 0.56); FDR <0.0001), sugar metabolism (2.28 (1.68 to 3.09); FDR <0.0001), branched-chain and aromatic amino acids (2.22 (1.60 to 3.08); FDR <0.0001), and fatty acid biosynthesis (1.54 (1.29 to 1.85); FDR <0.0001). Three additional clusters characterized by amino acid metabolism, cell membrane components, and aromatic amino acid metabolism displayed significant associations with prevalent T2D in the BPRHS, but these associations were not replicated in SOALS. Conclusions Among Puerto Rican adults, we identified several known and novel metabolite clusters that associated with prevalent T2D.

[1]  2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. , 2020, Diabetes care.

[2]  B. Cox,et al.  Diminished Sphingolipid Metabolism, a Hallmark of Future Type 2 Diabetes Pathogenesis, Is Linked to Pancreatic β Cell Dysfunction , 2020, iScience.

[3]  L. Brunham HDL and pancreatic β cells: a SMO-king gun?1 , 2020, Journal of Lipid Research.

[4]  A. Dömling,et al.  Metabolic signature of obesity-associated insulin resistance and type 2 diabetes , 2019, Journal of Translational Medicine.

[5]  M. Laakso Biomarkers for type 2 diabetes , 2019, Molecular metabolism.

[6]  A. Kostic,et al.  Understanding the growing epidemic of type 2 diabetes in the Hispanic population living in the United States , 2018, Diabetes/metabolism research and reviews.

[7]  Gad Getz,et al.  Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: A soft clustering analysis , 2018, PLoS medicine.

[8]  B. Dye,et al.  Longitudinal association between periodontitis and development of diabetes. , 2018, Diabetes research and clinical practice.

[9]  L. Groop,et al.  Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. , 2018, The lancet. Diabetes & endocrinology.

[10]  Thomas J. Wang,et al.  Metabolomics insights into early type 2 diabetes pathogenesis and detection in individuals with normal fasting glucose , 2018, Diabetologia.

[11]  E. Boerwinkle,et al.  Serum metabolomic profile of incident diabetes , 2018, Diabetologia.

[12]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association , 2018, Circulation.

[13]  T. Miyazaki,et al.  Increased N-Acetyltaurine in the Skeletal Muscle After Endurance Exercise in Rat. , 2018, Advances in experimental medicine and biology.

[14]  J. Pankow,et al.  Genetics of Type 2 Diabetes in U.S. Hispanic/Latino Individuals: Results From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) , 2017, Diabetes.

[15]  L. Simonsen,et al.  Transnational Mortality Comparisons Between Archipelago and Mainland Puerto Ricans , 2017, Journal of Immigrant and Minority Health.

[16]  C. Pérez,et al.  Cross‐sectional associations of impaired glucose metabolism measures with bleeding on probing and periodontitis , 2017, Journal of clinical periodontology.

[17]  Frank B Hu,et al.  Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis , 2016, Diabetes Care.

[18]  C. Pérez,et al.  Lipid-lowering agents use and systemic and oral inflammation in overweight or obese adult Puerto Ricans: the San Juan Overweight Adults Longitudinal Study (SOALS). , 2015, Journal of clinical periodontology.

[19]  Benjamin S. Glicksberg,et al.  Identification of type 2 diabetes subgroups through topological analysis of patient similarity , 2015, Science Translational Medicine.

[20]  Wanchang Lin,et al.  Untargeted metabolic profiling identifies altered serum metabolites of type 2 diabetes mellitus in a prospective, nested case control study. , 2015, Clinical chemistry.

[21]  Nicholette D. Palmer,et al.  Metabolomic profile associated with insulin resistance and conversion to diabetes in the Insulin Resistance Atherosclerosis Study. , 2015, The Journal of clinical endocrinology and metabolism.

[22]  Dean P. Jones,et al.  Novel Metabolic Markers for the Risk of Diabetes Development in American Indians , 2014, Diabetes Care.

[23]  Hugo A. Katus,et al.  A New Metabolomic Signature in Type-2 Diabetes Mellitus and Its Pathophysiology , 2014, PloS one.

[24]  R. Vasan,et al.  2-Aminoadipic acid is a biomarker for diabetes risk. , 2013, The Journal of clinical investigation.

[25]  Choon Nam Ong,et al.  Metabolic signature shift in type 2 diabetes mellitus revealed by mass spectrometry-based metabolomics. , 2013, The Journal of clinical endocrinology and metabolism.

[26]  V. Mootha,et al.  Circulating branched‐chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents , 2013, Pediatric obesity.

[27]  A. Peters,et al.  Identification of Serum Metabolites Associated With Risk of Type 2 Diabetes Using a Targeted Metabolomic Approach , 2013, Diabetes.

[28]  Susan Cheng,et al.  Metabolite Profiling Identifies Pathways Associated With Metabolic Risk in Humans , 2012, Circulation.

[29]  John P A Ioannidis,et al.  Improving Validation Practices in “Omics” Research , 2011, Science.

[30]  A. Lichtenstein,et al.  Adherence index based on the AHA 2006 diet and lifestyle recommendations is associated with select cardiovascular disease risk factors in older Puerto Ricans. , 2011, The Journal of nutrition.

[31]  F. Toledo,et al.  Increased Levels of Plasma Acylcarnitines in Obesity and Type 2 Diabetes and Identification of a Marker of Glucolipotoxicity , 2010, Obesity.

[32]  Sabrina E. Noel,et al.  The Boston Puerto Rican Health Study, a longitudinal cohort study on health disparities in Puerto Rican adults: challenges and opportunities , 2010, BMC public health.

[33]  Corey D. DeHaven,et al.  Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. , 2009, Analytical chemistry.

[34]  C. Hoppel,et al.  Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women. , 2009, The Journal of nutrition.

[35]  D. Sviridov,et al.  High-Density Lipoprotein Modulates Glucose Metabolism in Patients With Type 2 Diabetes Mellitus , 2009, Circulation.

[36]  Svati H Shah,et al.  A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. , 2009, Cell metabolism.

[37]  R. DeFronzo,et al.  Plasma Ceramides Are Elevated in Obese Subjects With Type 2 Diabetes and Correlate With the Severity of Insulin Resistance , 2009, Diabetes.

[38]  K. Dungan 1,5-anhydroglucitol (GlycoMark™) as a marker of short-term glycemic control and glycemic excursions , 2008, Expert review of molecular diagnostics.

[39]  E. Barnett,et al.  Diabetes-related mortality among Mexican Americans, Puerto Ricans, and Cuban Americans in the United States. , 2005, Revista panamericana de salud publica = Pan American journal of public health.

[40]  P. Loughna,et al.  C2C12 Skeletal Muscle Cells Exposure to Phosphatidylcholine Triggers IGF-1 Like-Responses , 2005, Cellular Physiology and Biochemistry.

[41]  M. Newman,et al.  Finding community structure in very large networks. , 2004, Physical review. E, Statistical, nonlinear, and soft matter physics.

[42]  A. Barabasi,et al.  Hierarchical Organization of Modularity in Metabolic Networks , 2002, Science.

[43]  Y. Benjamini,et al.  THE CONTROL OF THE FALSE DISCOVERY RATE IN MULTIPLE TESTING UNDER DEPENDENCY , 2001 .

[44]  K. Tucker,et al.  Adaptation of a food frequency questionnaire to assess diets of Puerto Rican and non-Hispanic adults. , 1998, American journal of epidemiology.

[45]  G. Marín,et al.  A New Measurement of Acculturation for Hispanics: The Bidimensional Acculturation Scale for Hispanics (BAS) , 1996 .

[46]  R S Paffenbarger,et al.  The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. , 1993, The New England journal of medicine.

[47]  T. Kamarck,et al.  A global measure of perceived stress. , 1983, Journal of health and social behavior.

[48]  L. Cowart,et al.  Sphingolipids in obesity, type 2 diabetes, and metabolic disease. , 2013, Handbook of experimental pharmacology.

[49]  Gábor Csárdi,et al.  The igraph software package for complex network research , 2006 .

[50]  R. Paffenbarger,et al.  Physical activity as an index of heart attack risk in college alumni. 1978. , 1995, American journal of epidemiology.